More on RXRX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+41.5% Growth)
- Ratings (4.0 Score)

Upcoming Events

- Earnings (8/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Recursion Pharmaceuticals (NQ:RXRX)
Delayed: 3.14 +0.03 (0.96%)
Prev. Close $3.11  
Open$3.18 
52 Wk High$ 
52 Wk Low$ 
Day High$3.28 
Day Low$3.11 
P/E N/A  
EPS$ 
Volume7,867,863 

Friends, Peers and Foes (?): DVAX, SDGR, RLYB, BDRX, TPST (more...)

Jun 18, 2026 09:45 AM Form 144 RECURSION PHARMACEUTICAL Filed by: Bumpus Namandje
Jun 18, 2026 09:37 AM Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher
Jun 17, 2026 05:07 PM Form 4 RECURSION PHARMACEUTICAL For: Jun 15 Filed by: Taylor Ben R
Jun 16, 2026 08:45 AM The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It
Jun 5, 2026 05:03 PM Form 4 RECURSION PHARMACEUTICAL For: Jun 05 Filed by: Gibson Christopher
Jun 5, 2026 05:03 PM Form 4 RECURSION PHARMACEUTICAL For: Jun 05 Filed by: Khan Najat
Jun 5, 2026 01:30 PM Form 144 RECURSION PHARMACEUTICAL Filed by: Khan Najat
Jun 5, 2026 10:19 AM Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher
Jun 4, 2026 05:05 PM Form 4 RECURSION PHARMACEUTICAL For: Jun 03 Filed by: Bumpus Namandje
Jun 4, 2026 05:05 PM Form 4 RECURSION PHARMACEUTICAL For: Jun 02 Filed by: Borgeson Blake
View All Articles

Entities mentioned with RXRX

View All Entities